Latest articles

The endometrial carcinoma market

Nature Reviews Drug Discovery, Published online: 21 January 2022; doi:10.1038/d41573-022-00016-2The endometrial carcinoma market

The endometrial carcinoma market

No shortage of fresh IPO capital in 2021

Nature Reviews Drug Discovery, Published online: 20 January 2022; doi:10.1038/d41573-022-00018-0No shortage of fresh IPO capital in 2021

No shortage of fresh IPO capital in 2021

PROTAC targeted protein degraders: the past is prologue

Nature Reviews Drug Discovery, Published online: 18 January 2022; doi:10.1038/s41573-021-00371-6Targeted protein degradation with proteolysis-targeting chimeras (PROTACs) has the potential to tackle disease-causing proteins that have historically been highly challenging to target with conventional small molecules. This article summarizes the first two...

PROTAC targeted protein degraders: the past is prologue

Biopharma dealmaking in 2021

Biopharma dealmaking in 2021

Nature Reviews Drug Discovery, Published online: 18 January 2022; doi:10.1038/d41573-022-00017-1Biopharma dealmaking in 2021

Immune targets for therapeutic development in depression: towards precision medicine

Nature Reviews Drug Discovery, Published online: 17 January 2022; doi:10.1038/s41573-021-00368-1Accumulating evidence suggests that, for some people, major depressive disorder has immunological roots. Here, Manji and colleagues discuss the progress towards immune-based treatments for depression, including which biomarkers might be most useful, as well...

Immune targets for therapeutic development in depression: towards precision medicine

Discover, share and read the best on the web

Follow RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters! Get unfiltered news feeds or filter them to your liking.

Get Inoreader
Inoreader - Follow RSS Feeds, Blogs, Podcasts, Twitter searches, Facebook pages, even Email Newsletters!